Bartels Matthew N, Jelic Sanja, Ngai Pakkay, Basner Robert C, DeMeersman Ronald E
Human Performance Laboratory, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.
Chest. 2003 Sep;124(3):863-9. doi: 10.1378/chest.124.3.863.
STUDY OBJECTIVES: To evaluate cardiac autonomic modulation in patients with COPD during peak exercise. METHODS: Fifty-three patients with COPD (mean FEV(1), 35% predicted [SD, 11% predicted]; mean PaO(2), 68 mm Hg [SD, 11 mm Hg]; mean PaCO(2), 40 mm Hg [SD, 7 mm Hg]; mean age, 61 years [SD, 10 years]; 26 women and 27 men) and 14 healthy control subjects aged 60 years (SD, 8 years) [seven women and seven men] were studied at rest and during ramped bicycle ergometry to their volitional peak. Patients were not receiving autonomic medications other than inhaled beta-agonist agents and/or anticholinergic agents. Control subjects were not receiving any medications. Cardiac autonomic modulation was assessed via time-frequency analysis (Wigner-Ville) of ECG-derived heart rate variability as the power in the low-frequency (LF) band (ie, 0.04 to 0.15 Hz) and the high-frequency (HF) band (ie, > 0.15 to 0.4 Hz) averaged from > 3 min at rest and minutes 2 through 5 of their exercise period. RESULTS: Patients with COPD had a significantly increased mean, ln-transformed HF band from rest to peak exercise (9.9 ms(2) [SD, 1.4 ms(2)] vs 10.7 ms(2) [SD, 1.4 ms(2)], respectively; p < 0.01), while the HF band was unchanged for the control group (10.7 ms(2) [SD, 1.5 ms(2)] vs 10.4 ms(2) [1.3 ms(2)], respectively; difference not significant). The mean ln-transformed LF band was significantly increased from rest to peak exercise in patients with COPD (10.9 ms(2) [SD, 1.5 ms(2)] vs 11.5 ms(2) [SD, 1.4 ms(2)], respectively; p < 0.01) and in control subjects (10.9 ms(2) [SD, 1.5 ms(2)] vs 11.5 ms(2) [SD, 1.3 ms(2)], respectively; p < 0.01). The mean LF/HF ratio was significantly decreased from rest to peak exercise in patients with COPD (3.1 [SD, 1.5] vs 2.5 [SD, 1.0], respectively; p < 0.01) and was increased in control subjects (1.9 [SD, 0.8] vs 2.4 [1.0], respectively; p < 0.01). When expressed in normalized units ([absolute power of the components]/[total power - very low frequency power] x 100), the HF band was again significantly greater during peak exercise than at rest in the patients with COPD and was unchanged during peak exercise for the control group. Autonomic changes were not significantly correlated with age, gender, body mass index, spirometry, lung volumes, resting gas exchange, or oxygen saturation during exercise. CONCLUSION: These data suggest that, in contrast to control subjects, the balance of sympathetic to parasympathetic cardiac modulation decreases in patients with COPD during maximal volitional exercise.
研究目的:评估慢性阻塞性肺疾病(COPD)患者在运动峰值时的心脏自主神经调节情况。 方法:对53例COPD患者(平均第1秒用力呼气容积[FEV(1)]为预计值的35%[标准差,预计值的11%];平均动脉血氧分压[PaO(2)]为68 mmHg[标准差,11 mmHg];平均动脉血二氧化碳分压[PaCO(2)]为40 mmHg[标准差,7 mmHg];平均年龄61岁[标准差,10岁];26例女性和27例男性)和14名年龄60岁(标准差,8岁)的健康对照者(7名女性和7名男性)进行静息状态及渐增负荷自行车运动至其意愿峰值时的研究。患者除吸入β受体激动剂和/或抗胆碱能药物外未接受自主神经药物治疗。对照者未接受任何药物治疗。通过对心电图衍生的心率变异性进行时频分析(维格纳-威利分布)来评估心脏自主神经调节,分别计算静息状态下>3分钟及运动期第2至5分钟的低频(LF)频段(即0.04至0.15 Hz)和高频(HF)频段(即>0.15至0.4 Hz)的功率。 结果:COPD患者从静息到运动峰值时,经自然对数转换后的HF频段均值显著增加(分别为9.9 ms(2)[标准差,1.4 ms(2)]和10.7 ms(2)[标准差,1.4 ms(2)];p<0.01),而对照组HF频段无变化(分别为10.7 ms(2)[标准差,1.5 ms(2)]和10.4 ms(2)[1.3 ms(2)];差异无统计学意义)。COPD患者从静息到运动峰值时,经自然对数转换后的LF频段均值显著增加(分别为10.9 ms(2)[标准差,1.5 ms(2)]和11.5 ms(2)[标准差,1.4 ms(2)];p<0.01),对照者也如此(分别为10.9 ms(2)[标准差,1.5 ms(2)]和11.5 ms(2)[标准差,1.3 ms(2)];p<0.01)。COPD患者从静息到运动峰值时,平均LF/HF比值显著降低(分别为3.1[标准差,1.5]和2.5[标准差,1.0];p<0.01),对照者则升高(分别为1.9[标准差,0.8]和2.4[1.0];p<0.01)。以标准化单位表示([各成分的绝对功率]/[总功率 - 极低频功率]×100)时,COPD患者运动峰值时的HF频段再次显著高于静息时,而对照组运动峰值时无变化。自主神经变化与年龄、性别、体重指数、肺功能、肺容积、静息气体交换或运动时的氧饱和度无显著相关性。 结论:这些数据表明,与对照者相比,COPD患者在最大意愿运动时心脏交感神经与副交感神经调节的平衡降低。
Int J Chron Obstruct Pulmon Dis. 2017-7-28
Int J Chron Obstruct Pulmon Dis. 2016-7-26
Int J Chron Obstruct Pulmon Dis. 2017-3-13
Int J Chron Obstruct Pulmon Dis. 2015-1-29
Front Cardiovasc Med. 2023-2-17
Respir Physiol Neurobiol. 2013-5-10